Biotechnology News

August 30, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule will present at three upcoming investment conferences.

August 30, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that David Perry, the company’s Chief Executive Officer, will provide a company overview at the Stifel Nicolaus 2012 Healthcare Conference on Wednesday,...

August 30, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. announced that Tetraphase President & Chief Executive Officer Guy Macdonald will present at the Stifel Nicolaus 2012 Healthcare Conference on September 5, 2012

August 30, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the Rodman & Renshaw Annual Global Investment Conference, being held September 10-11, 2012 at The Waldorf Astoria in...

August 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the Stifel Nicolaus Healthcare Conference on September 5, 2012 at 1:30 p.m. ET in Boston. In addition, Infinity will be presenting at the...

August 30, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today announced that it will present at the Stifel...

August 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem will present at several upcoming investment conferences.

August 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the submission of a Marketing Authorization Application (MAA) for its investigational BCR-ABL inhibitor, ponatinib, to the European Medicines Agency (...

August 30, 2012

AARHUS, Denmark--(BUSINESS WIRE)--CLC bio, the world's leading bioinformatics software developer, has been awarded a share of a EU-funded clinical research grant, PATHSEEK, worth $ 2M out of a total project budget of $ 10M.

August 30, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals will present at the Stifel Nicolaus Healthcare Conference and BioCentury’s 19th Annual NewsMakers in the Biotech Industry conference.

August 30, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Completes Enrollment in Phase 1b Trial of RNAi Drug Candidate CALAA-01

August 30, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm announced that Igor Gonda, Aradigm’s CEO, will be a panel member at the FDA’s public workshop on the design of clinical trials of antibacterial drugs for non-cystic fibrosis bronchiectasis

August 30, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Paul K. Wotton, Ph.D., President and Chief Executive Officer, will present at the Stifel Nicolaus 2012 Healthcare Conference on Thursday, September 6, 2012 at...

August 30, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals Announces One-to-One Conversion of Class B Common Stock into Class A Common Stock

August 30, 2012

SANTA ANA, Calif.--(BUSINESS WIRE)--MP Biomedicals, LLC, a leading provider of life science reagents, fine chemicals and diagnostic products for over 50 years, announced today it has launched a new website.

August 30, 2012

SYDNEY--(BUSINESS WIRE)--Sirtex Medical Limited, ASX:SRX, revenue growth, biotechnology, medical technology, liver cancer, oncology.

August 30, 2012

IRVINE, Calif. & LIEGE, Belgium--(BUSINESS WIRE)--Regulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, announced today its...

August 30, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Elekta (STO:EKTAB) has won a major tender where the Health Department of the People’s Liberation Army (PLA) is expanding its capacity to treat cancer. Cancer is one of the leading causes of death in...

August 30, 2012

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that A. Collier Smyth, Gerhard Waldheim and Wayne P. Yetter have resigned from the Company’s Board of Directors...

August 29, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec to Present at Stifel Nicolaus Healthcare Conference

August 29, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) today was notified by the Food and Drug Administration (the “FDA”) that the Company’s new drug application (“NDA”) for cabozantinib as a treatment for patients with...

August 29, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE:ELN) today announced that it has commenced a Phase 2, placebo-controlled, safety and efficacy study of oral ELND005 as an adjunctive maintenance treatment in patients with Bipolar I Disorder (...

August 29, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals to Present at Investment Conferences

August 29, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) announced today that District Judge Sue L. Robinson of the U.S. District Court for the District of Delaware granted Illumina’s motion for summary judgment of invalidity of U.S. Patent No....

August 29, 2012

BOULDER, Colo.--(BUSINESS WIRE)--ARRAY BIOPHARMA TO PRESENT AT THE STIFEL NICOLAUS HEALTHCARE, NEWSMAKERS IN THE BIOTECH INDUSTRY AND MORGAN STANLEY GLOBAL HEALTHCARE CONFERENCES

August 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Stifel Nicolaus Healthcare Conference on Thursday,...

August 29, 2012

MAYNARD, Mass.--(BUSINESS WIRE)--Allegro Diagnostics is participating in the GTC Biomarkers Europe Summit in Zurich and BioPharm America in Boston during September 2012.

August 29, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services to the global health science market, today announced that the Company will report its third quarter 2012 financial results after...

August 29, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River acquires Accugenix, Inc., the premier global provider of cGMP-compliant contract microbial identification testing

August 29, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) reports that U.S. researchers have found that Thymosin Beta 4 (Tβ4) promotes statistically significant recovery of...

August 29, 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/...

August 29, 2012

NEW YORK--(BUSINESS WIRE)--The Effie Awards, honoring marketing effectiveness, announced the newly launched North American Health Effie Award, focusing on marketing OTC and Rx healthcare products and services in North America.

August 29, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Aerial BioPharma, a biopharmaceutical company focused on developing biologics and small molecules for conditions in the central nervous system, has received orphan drug designation for its narcolepsy drug in...

August 29, 2012

TORONTO--(BUSINESS WIRE)--CardioComm Solutions, Inc. Receives Health Canada Clearance to Market the HeartCheck™ ECG Monitor as a Prescription Product.Canadian Approval is the first of three Health Canada Applications.

August 29, 2012

MIAMI & NEW YORK--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has submitted to the U.S. Food & Drug Administration a New Drug Application (NDA)...

August 29, 2012

SAN ANTONIO--(BUSINESS WIRE)--The NAFTA20 North America Business Summit, will be held at The Westin La Cantera Resort in San Antonio on Nov. 15 and 16, 2012. It will focus on strategic outlooks future of NAFTA.

August 29, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Vikas Sinha, Chief Financial Officer of Alexion Pharmaceuticals, will present at two upcoming investor conferences: Robert W. Baird & Co. 2012...

August 29, 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/...

August 29, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will present at the Stifel Nicolaus Healthcare Conference on Wednesday, September 5 at 9:10 a.m. (ET) in Boston.

August 29, 2012

SEATTLE--(BUSINESS WIRE)--Pfizer selects next target in antibody discovery collaboration with Theraclone Sciences. This is the third target chosen in the collaboration that began in January 2011.

August 29, 2012

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today that it will participate in ThinkEquity’s 9th Annual Growth Conference on Thursday, September 13th at 9:00 AM Eastern Time at the Le...

August 29, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida CEO to discuss sustained delivery and nanotechnology in ophthalmology at drug delivery technology conference in Switzerland

August 29, 2012

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced...

August 29, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics Inc. (NASDAQ: GALT) appoints Dr. Harold H. Shlevin as Chief Operating Officer, succeeding Maureen Foley as of October 1, 2012.

August 29, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that Alan A. Musso, Senior Vice President, Finance and Administration and...

August 29, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Dr. Laurence Corash, chief medical officer of Cerus, is scheduled to present a corporate update at the Stifel Nicolaus Weisel Healthcare Conference in Boston on Sept 5, 2012.

August 29, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company management will discuss Cubist’s business activities and financial outlook at investor conferences during September 2012. Michael Bonney,...

August 29, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Protalex, Inc. (OTCBB: PRTX), a clinical stage biopharmaceutical company focused on the development of a class of drugs designed to treat autoimmune and inflammatory diseases including rheumatoid arthritis (RA),...